Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Orvig

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Neurotoxicology|January 1, 1994
Pharmacokinetics and distribution of tris(maltolato)aluminum(III) into the central nervous systemD D Allen, C Orvig, R A Yokel
The American Journal of Physiology|January 1, 1997
Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic ratsV G Yuen, C Orvig, J H McNeill
Inorganic Chemistry|April 17, 2001
Chemistry of re with N,N'-bis(2-pyridylmethyl)ethylenediamine (H2pmen): hydrolysis, dehydrogenation, and ternary complexesL Xu, J Pierreroy, B O Patrick, et al.
Inorganic Chemistry|August 21, 2001
[ReO(N2O2)X] complexes: "4 + 1"?L Xu, M P Lowe, S J Rettig, et al.
Inorganic Chemistry|March 7, 2001
Homotrinuclear lanthanide(III) arrays: assembly of and conversion from mononuclear and dinuclear unitsI A Setyawati, S Liu, S J Rettig, et al.
Molecular and Cellular Biochemistry|December 6, 1995
Increased potency of vanadium using organic ligandsJ H McNeill, V G Yuen, S Dai, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|April 1, 1992
Potential 67Ga radiopharmaceuticals for myocardial imaging: tris(1-aryl-3-hydroxy-2-methyl-4-pyridinonato)gallium(III) complexesZ Zhang, D M Lyster, G A Webb, et al.
Metal Ions in Biological Systems|January 1, 1995
Vanadium compounds as insulin mimicsC Orvig, K H Thompson, M Battell, et al.
Journal of Medicinal Chemistry|April 17, 1992
Bis(maltolato)oxovanadium(IV) is a potent insulin mimicJ H McNeill, V G Yuen, H R Hoveyda, et al.
Canadian Journal of Physiology and Pharmacology|March 1, 1993
Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV)V G Yuen, C Orvig, K H Thompson, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Neurotoxicology|January 1, 1994
Pharmacokinetics and distribution of tris(maltolato)aluminum(III) into the central nervous systemD D Allen, C Orvig, R A Yokel
The American Journal of Physiology|January 1, 1997
Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic ratsV G Yuen, C Orvig, J H McNeill
Inorganic Chemistry|April 17, 2001
Chemistry of re with N,N'-bis(2-pyridylmethyl)ethylenediamine (H2pmen): hydrolysis, dehydrogenation, and ternary complexesL Xu, J Pierreroy, B O Patrick, et al.
Inorganic Chemistry|August 21, 2001
[ReO(N2O2)X] complexes: "4 + 1"?L Xu, M P Lowe, S J Rettig, et al.
Inorganic Chemistry|March 7, 2001
Homotrinuclear lanthanide(III) arrays: assembly of and conversion from mononuclear and dinuclear unitsI A Setyawati, S Liu, S J Rettig, et al.
Molecular and Cellular Biochemistry|December 6, 1995
Increased potency of vanadium using organic ligandsJ H McNeill, V G Yuen, S Dai, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|April 1, 1992
Potential 67Ga radiopharmaceuticals for myocardial imaging: tris(1-aryl-3-hydroxy-2-methyl-4-pyridinonato)gallium(III) complexesZ Zhang, D M Lyster, G A Webb, et al.
Metal Ions in Biological Systems|January 1, 1995
Vanadium compounds as insulin mimicsC Orvig, K H Thompson, M Battell, et al.
Journal of Medicinal Chemistry|April 17, 1992
Bis(maltolato)oxovanadium(IV) is a potent insulin mimicJ H McNeill, V G Yuen, H R Hoveyda, et al.
Canadian Journal of Physiology and Pharmacology|March 1, 1993
Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV)V G Yuen, C Orvig, K H Thompson, et al.
Pageof 4